| Date Filed | Type | Description |
| 03/22/2023 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 4,410 shares
@ $7.76, valued at
$34.2k
|
|
| 02/22/2023 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 3,297 shares
@ $7.45, valued at
$24.6k
|
|
| 01/19/2023 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 1,396 shares
@ $9.57, valued at
$13.4k
Sold 792 shares
@ $10.34, valued at
$8.2k
|
|
| 04/06/2022 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 2,786 shares
@ $8.25, valued at
$23k
|
|
| 03/23/2022 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 4,897 shares
@ $8.29, valued at
$40.6k
Sold 58 shares
@ $8.68, valued at
$503.4 |
|
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 3,252 shares
@ $3.36, valued at
$10.9k
|
|
| 01/18/2022 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 120,000 options to buy
@ $2.85, valued at
$342k
|
|
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 3,091 shares
@ $8.51, valued at
$26.3k
|
|
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
4
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 28,125 shares
@ $0
Granted 168,750 options to buy
@ $19.79, valued at
$3.3M
|
|
| 04/03/2019 |
3
| Hesslein Robert W. (Senior VP & General Counsel) has filed a Form 3 on Voyager Therapeutics, Inc. |
| 08/02/2018 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Unknown transaction of 76,494 shares
@ $137, valued at
$10.5M
Disposed of 28,709 shares
@ $137, valued at
$3.9M
|
|
| 07/05/2018 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 2,520 shares
@ $136.66, valued at
$344.4k
|
|
| 04/03/2018 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Granted 8,621 shares
@ $78.75, valued at
$678.9k
Sold 1,585 shares
@ $74.88, valued at
$118.7k
Exercised 2,344 options to buy
@ $7.12, valued at
$16.7k
|
|
| 01/18/2018 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 18,021 shares
@ $64.3, valued at
$1.2M
|
|
| 01/03/2018 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 1,392 shares
@ $64, valued at
$89.1k
Sold 472 shares
@ $64, valued at
$30.2k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2017 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 1,009 shares
@ $33.87, valued at
$34.2k
|
|
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2017 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 1,233 shares
@ $31.96, valued at
$39.4k
|
|
| 03/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/11/2016 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Exercised 6,253 options to buy
@ $4.16, valued at
$26k
Exercised 3,124 options to buy
@ $7.12, valued at
$22.2k
|
|
| 04/06/2016 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Granted 45,000 shares
@ $18.25, valued at
$821.3k
|
|